Praxis Precision Medicines Inc (PRAX) — Financial Flexibility Index
Praxis Precision Medicines Inc (PRAX) has a Financial Flexibility Index of -1.71x as of March 2026. Free cash flow of $-85.99 Million (operating CF $-86.05 Million minus capex $62.00K) represents -2% of total liabilities ($50.24 Million). Also explore PRAX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Praxis Precision Medicines Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Praxis Precision Medicines Inc across 8 annual periods. Check Praxis Precision Medicines Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Praxis Precision Medicines Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Praxis Precision Medicines Inc. For the full company profile including market capitalisation, see market value of Praxis Precision Medicines Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.17x | $-249.01 Million | $-249.07 Million | $59.77 Million | ▼ -19.1% |
| 2024 | -3.50x | $-131.76 Million | $-131.76 Million | $37.66 Million | ▲ +42.4% |
| 2023 | -6.08x | $-111.09 Million | $-111.14 Million | $18.28 Million | ▼ -28.5% |
| 2022 | -4.73x | $-184.60 Million | $-185.04 Million | $39.02 Million | ▼ -60.6% |
| 2021 | -2.95x | $-123.50 Million | $-124.55 Million | $41.94 Million | ▲ +12.0% |
| 2020 | -3.35x | $-52.62 Million | $-52.62 Million | $15.72 Million | ▲ +22.4% |
| 2019 | -4.31x | $-32.68 Million | $-32.79 Million | $7.58 Million | ▼ -7.4% |
| 2018 | -4.01x | $-20.66 Million | $-20.72 Million | $5.15 Million | — |